Non-HSR Reportable Transactions

Determining Merger Clearance Options, Conducting Antitrust Risk Assessment, and Minimizing Likelihood of Government Investigation

Recording of a 90-minute CLE webinar with Q&A


Conducted on Wednesday, June 5, 2013

Recorded event now available

or call 1-800-926-7926
Program Materials

This CLE webinar will examine the antitrust risks involved in non-HSR reportable transactions and the increased agency scrutiny. The panel will discuss early risk assessment and options for merger clearance and will offer strategies for reducing the likelihood of government investigations.

Description

Transactions that exceed the $70.9 million size of transaction threshold must be reported. Deals below that threshold may be expected to escape agency scrutiny. However, the lack of a Hart-Scott-Rodino filing does not preclude government examination. Non-reportable deals are challenged by the FTC and DOJ.

In Jan. 2013, the DOJ challenged Bazaarvoice Inc.’s acquisition of PowerReviews Inc., even though the transaction did not satisfy the reporting thresholds. In March 2012, the FTC ordered ProMedica Health Systems to divest St. Luke’s Hospital, the purchase of which also fell below the reporting threshold.

Counsel must carefully consider the potential for antitrust review and enforcement and evaluate how best to respond to any antitrust risk in the transaction.

Listen as our authoritative panel of antitrust attorneys examines the antitrust risks involved in non-HSR reportable transactions and increased enforcement by the FTC and DOJ. The panel will discuss early risk assessment and options for merger clearance and will offer strategies for reducing the likelihood of government investigations.

READ MORE

Outline

  1. Antitrust risks in non-reportable transactions
  2. Enforcement trends
  3. Risk assessment
  4. Options for merger clearance
  5. Best practices to reduce likelihood of government investigations

Benefits

The panel will review these and other key questions:

  • What are the antitrust risks of non-HSR reportable transactions?
  • What are the lessons from recent government action in transactions below the reporting threshold?
  • What practices can counsel implement to effectively review the potential competitive effects of proposed transactions?

Following the speaker presentations, you'll have an opportunity to get answers to your specific questions during the interactive Q&A.

Faculty

Laura Kam
Laura Kam

Of Counsel
DLA Piper LLP (US)

Ms. Kam focuses on complex commercial litigation and antitrust matters. She counsels clients on antitrust...  |  Read More

Mary Anne Mason
Mary Anne Mason

Of Counsel
DLA Piper

Ms. Mason practices antitrust, competition and economic regulatory law. Her government investigations practice...  |  Read More

J. Robert Robertson
J. Robert Robertson

Partner
Hogan Lovells US

His practice focuses primarily on antitrust, consumer protection, and commercial litigation. He is the former Chief...  |  Read More

Other Formats
— Anytime, Anywhere

Strafford will process CLE credit for one person on each recording. All formats include program handouts. To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Audio

$297

Download

$297